Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Tan Sheet

Executive Summary

Safety and regulatory appropriateness of emergency contraceptives available without a prescription stressed by David Grimes, MD, Family Health International, et al., in July issue of Obstetrics & Gynecology. Authors discuss medical and legal implications of issue, arguing "unintended pregnancies remain endemic in the United States, and wider use of emergency contraceptive pills could substantially help." Family Health International has been helping to design label comprehension and actual use studies to support a switch NDA for Women's Capital Corporation's Plan B (1"The Tan Sheet" Dec. 18, 2000, p. 3)

You may also be interested in...

Plan B Emergency Contraceptive Switch NDA Planned

Women's Capital Corporation will file an NDA next year to switch its Plan B emergency contraceptive to OTC status, the company said Dec. 13.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts